Open access · CC-BY
via OpenAlex
Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
Patricia Luz‐Crawford, Danièle Noël, Fernandez Ximena, Maroun Khoury, Fernando Figueroa, Flavio Carrión, Christian Jørgensen, Farida Djouad
PLoS ONE · 2012 · ▲ 200 citations
Abstract
MSC display potent suppressive properties initially described a decade ago. More recently, MSC suppressive activities on T-cell effector pathways have been investigated. MSC modulate CD4 differentiation through different mechanisms depending on culture conditions and display disparate activities on T cells according to their differentiation status. A significant amount of evidence for MSC effects on Th17 cells revealed that MSC could be suppressive under diverse circumstances but also enhance Th17 cell activity under other conditions. In the present study, we investigated the suppressive effects of MSC on Th1 and Th17 subsets of T cells using T cells undergoing Th1 and Th17 polarization or mature Th1 and Th17 cells. MSC inhibited the proliferation of T cells during their differentiation toward Th1 cells and mature Th1 cells. This suppressive effect was maintained in a transwell cell culture insert demonstrating the major role played by soluble factors. Using the transwell cell separation barrier, we observed that MSC decrease the number of T cells undergoing Th17 differentiation whereas they did not affect IL-17 production by mature Th17, demonstrating the need for cell contact for suppressing Th17 cell function. Moreover, we reported that PD-L1 is highly expressed on MSC co-cultured with differentiating or polarized Th1 and Th17 cells. Using neutralizing antibodies specific for PD-L1 and PD-1 we showed that the mechanisms by which MSC mediate Th17 cell repolarization depend on PD-L1 expression on MSC. Taken together our results demonstrated a cell-to-cell contact depend mechanism in the selective immunosuppression of MSC on mature Th17 cells through up-regulation of PD-L1.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0045272
- Canonical
- link ↗
- Fetched
- 2026-06-11 MST
Cite this
APA
Luz‐Crawford, P., Noël, D., Ximena, F., Khoury, M., Figueroa, F., Carrión, F., Jørgensen, C., & Djouad, F. (2012). Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0045272
Vancouver
Luz‐Crawford P, Noël D, Ximena F, Khoury M, Figueroa F, Carrión F, et al. Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway. PLoS ONE. 2012. doi:10.1371/journal.pone.0045272.
BibTeX
@article{patricia2012Mesenc,
title = {Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway},
author = {Patricia Luz‐Crawford and Danièle Noël and Fernandez Ximena and Maroun Khoury and Fernando Figueroa and Flavio Carrión and Christian Jørgensen and Farida Djouad},
journal = {PLoS ONE},
year = {2012},
doi = {10.1371/journal.pone.0045272},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC Cell Biology 2008
Open access · CC-BY
Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells
Stem Cells Translational Medicine 2013
Open access · OA
Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts
Nutrients 2019
Open access · CC-BY
The Effects of Calorie Restriction on Autophagy: Role on Aging Intervention
Signal Transduction and Targeted Therapy 2023
Open access · CC-BY
The mitophagy pathway and its implications in human diseases
Biological Chemistry 2012
Open access · OA
Integration of cellular bioenergetics with mitochondrial quality control and autophagy
Clinical and Translational Medicine 2016
Open access · CC-BY